Anaplastic lymphoma kinase (ALK) positive diffuse large B cell lymphoma in a 20 year old: A rare entity

Anaplastic lymphoma kinase (ALK) positive diffuse large B cell lymphoma in a 20 year old: A rare entity

Bibliographic Details
Main Authors:	Ritesh Sachdev, Shalini Goel, Sunil Gupta, Nitin Sood
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2014-01-01
Series:	Indian Journal of Pathology and Microbiology
Online Access:	http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2014;volume=57;issue=1;spage=157;epage=158;aulast=Sachdev

Similar Items

ALK Positive Anaplastic Large Cell Lymphoma Presenting as Extensive Bone Involvement
by: Smeeta Gajendra, et al.
Published: (2015-01-01)

An Exploration into the Origins and Pathogenesis of Anaplastic Large Cell Lymphoma, Anaplastic Lymphoma Kinase (ALK)-Positive
by: Suzanne D. Turner
Published: (2017-10-01)

Anaplastic lymphoma kinase positive variant of anaplastic large cell lymphoma: A rare entity
by: Venkata Satya Ramesh Thummala, et al.
Published: (2014-01-01)

From Pathology to Precision Medicine in Anaplastic Large Cell Lymphoma Expressing Anaplastic Lymphoma Kinase (ALK+ ALCL)
by: Michael T. Werner, et al.
Published: (2017-10-01)

Inhibition of anaplastic lymphoma kinase (ALK) activity provides a therapeutic approach for CLTC-ALK-positive human diffuse large B cell lymphomas.
by: Leandro Cerchietti, et al.
Published: (2011-01-01)

Mechanistic Implications and Characterization of Anaplastic Lymphoma Kinase (ALK) mutations in Neuroblastoma
by: Chand, Damini
Published: (2015)

Anaplastic lymphoma kinase (ALK) positive anaplastic large cell lymphoma (ALCL) of breast in a patient without a breast implant
by: Vishwanath Sathyanarayanan, et al.
Published: (2014-11-01)

Therapeutic Targeting of the Anaplastic Lymphoma Kinase (ALK) in Neuroblastoma—A Comprehensive Update
by: Annette K. Brenner, et al.
Published: (2021-09-01)

Development of anaplastic lymphoma kinase (ALK) inhibitors and molecular diagnosis in ALK rearrangement-positive lung cancer
by: Iwama E, et al.
Published: (2014-03-01)

Alectinib, an Anaplastic Lymphoma Kinase Inhibitor, Abolishes ALK Activity and Growth in ALK-Positive Neuroblastoma Cells
by: Muhammad Wasi Alam, et al.
Published: (2019-07-01)

Anaplastic lymphoma kinase–positive anaplastic large cell lymphoma presenting as diffuse pulmonary infiltrates
by: Shuku Sato, et al.
Published: (2020-10-01)

Primary testicular plasmablastic lymphoma: unique case in a 30 year old
by: Ritesh Sachdev, et al.
Published: (2016-01-01)

Anaplastic Lymphoma Kinase (ALK) Receptor Tyrosine Kinase: A Catalytic Receptor with Many Faces
by: Hao Huang
Published: (2018-11-01)

Pathobiology of ALK-negative anaplastic large cell lymphoma
by: Stefano A. Pileri, et al.
Published: (2011-06-01)

Novel Molecular Challenges in Targeting Anaplastic Lymphoma Kinase in ALK-Expressing Human Cancers
by: Abdulraheem Alshareef
Published: (2017-10-01)

Analysis of Histologic Features Suspecting Anaplastic Lymphoma Kinase (ALK)-Expressing Pulmonary Adenocarcinoma
by: In Ho Choi, et al.
Published: (2015-07-01)

Synchronous Diffuse Large B-Cell Lymphoma and Malignant Clonal Plasma Cells in Bone Marrow As Primary Presentation: A Diagnostic and Therapeutic Challenge
by: Ritesh Sachdev, et al.
Published: (2015-04-01)

Developments in anaplastic large-cell lymphoma: targeting the anaplastic lymphoma kinase
by: Farina F, et al.
Published: (2014-08-01)

Alectinib, an anaplastic lymphoma kinase (ALK) inhibitor, as a bridge to allogeneic stem cell transplantation in a patient with ALK‐positive anaplastic large‐cell lymphoma refractory to chemotherapy and brentuximab vedotin
by: Ritsuko Nakai, et al.
Published: (2019-12-01)

ALK kinase domain mutations in primary anaplastic large cell lymphoma: consequences on NPM-ALK activity and sensitivity to tyrosine kinase inhibitors.
by: Federica Lovisa, et al.
Published: (2015-01-01)

Educational Case: ALK-Negative Anaplastic Large Cell Lymphoma
by: Akira Satou MD, PhD, et al.
Published: (2020-01-01)

ALK signaling and target therapy in anaplastic large cell lymphoma
by: Fabrizio eTabbo, et al.
Published: (2012-05-01)

Primary gastric anaplastic lymphoma kinase-negative anaplastic large-cell lymphoma
by: Tian C, et al.
Published: (2016-09-01)

Anaplastic Lymphoma Kinase-Negative Anaplastic Large Cell Lymphoma with Colon Involvement
by: Yuko Sakakibara, et al.
Published: (2015-01-01)

Leukemic phase of anaplastic lymphoma kinase positive, anaplastic large cell lymphoma
by: Vijaya S Gadage, et al.
Published: (2011-01-01)

Immune Response against ALK in Children with ALK-Positive Anaplastic Large Cell Lymphoma
by: Serena Stadler, et al.
Published: (2018-04-01)

Structural Biology Studies reveal the Conformational Switching of Anaplastic Lymphoma Kinase (ALK) by Pyrazolylamine Derivatives
by: Tu, Chih-Hsiang, et al.
Published: (2016)

Anaplastic lymphoma kinase (ALK) gene alteration in signet ring cell carcinoma of the gastrointestinal tract
by: Olatunji B. Alese, et al.
Published: (2015-03-01)

Hemolytic anemia caused by alectinib, an Anaplastic Lymphoma Kinase (ALK) inhibitor: A case report
by: Aerts, R., et al.
Published: (2022)

Novel covalent modification of human anaplastic lymphoma kinase (ALK) and potentiation of crizotinib-mediated inhibition of ALK activity by BNP7787
by: Parker AR, et al.
Published: (2015-02-01)

Systematic Review and Network Meta-Analysis of Anaplastic Lymphoma Kinase (ALK) Inhibitors for Treatment-Naïve ALK-Positive Lung Cancer
by: Cheng-Hao Chuang, et al.
Published: (2021-04-01)

Unusually Aggressive Primary Testicular Diffuse Large B Cell Lymphoma with Post Therapy Extensive Metastasis
by: Shalini Goel, et al.
Published: (2016-07-01)

Pharmacological inhibitors of anaplastic lymphoma kinase (ALK) induce immunogenic cell death through on-target effects
by: Adriana Petrazzuolo, et al.
Published: (2021-07-01)

The function and therapeutic targeting of anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC)
by: Brandon Golding, et al.
Published: (2018-02-01)

Anaplastic lymphoma kinase (ALK) inhibitors for second-line therapy of non-small cell lung cancer
by: Berghmans T, et al.
Published: (2012-12-01)

MOLECULAR BIOLOGICAL CHARACTERISTICS OF ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA
by: E. V. Chernyshova, et al.
Published: (2017-01-01)

Anaplastic Lymphoma Kinase in Cutaneous Malignancies
by: Severine Cao, et al.
Published: (2017-09-01)

Investigating the function of Anaplastic Lymphoma Kinase
by: Vernersson Lindahl, Emma
Published: (2008)

Cleavage of the Anaplastic Lymphoma Kinase in Neuroblastoma
by: Yeung, Caleb Matthew
Published: (2016)

Anaplastic lymphoma kinase immunocytochemistry in fine needle aspiration diagnosis of anaplastic large-cell lymphoma
by: Prashant Ramteke, et al.
Published: (2018-01-01)

Cannot write session to /tmp/vufind_sessions/sess_ltc7aj08d8ht1rcj68v3l328pl